Background: Delirium is a common complication of hip fracture and is associated with negative outcomes. Previous studies document risk factors for post-operative delirium but have frequently excluded patients with pre-operative delirium. Objective: This study endeavours to document prevalence and risk factors for pre-operative delirium in hip fracture patients and compares risk factor profiles and outcomes between pre- and post-operative delirium. Methods: 283 hip fracture patients were assessed pre-operatively with the Delirium Elderly At Risk (DEAR) instrument, Mini-Mental State Examination (MMSE), and Confusion Assessment Method (CAM). They were followed on post-operative days 1, 3, and 5 for the presence of delirium. Doses of opioids were recorded. Wait time to surgery, length of stay, and discharge site were noted. Results: Delirium was present in 57.6% patients pre-operatively and 41.7% post-surgery. Not all patients (62%) with pre-operative delirium also had post-operative delirium. There was a considerable overlap in risk factors, with some differences. Wait time to surgery, number of comorbidities, and total pre-operative opioid and lorazepam doses were associated with pre- but not post-operative delirium. Negative outcomes were more closely associated with post-operative delirium. Conclusion: Delirium is common in pre-hip fracture surgery patients, and not all patients with pre-operative delirium go on to have post-operative delirium. Risk factor profiles are not identical, raising the possibility of identifying and intervening in patients at high risk of delirium pre-operatively.

Keywords:
Pre-operative, Hip fracture, Delirium
1.
Chaudhry H, Devereaux P, Bhandari M: Cognitive dysfunction in hip fracture patients. Orthop Clin N Am 2013;44:153-162.
2.
Bruce AJ, Ritchie CW, Blizard R, Lai R, Raven P: The incidence of delirium associated with orthopedic surgery: a meta-analytic review. Int Psychogeriatr 2007;19:197-214.
3.
Juliebo V, Bjoro K, Krogseth M, Skovlund E, Ranhoff AH, Wyller TB: Risk factors for preoperative and postoperative delirium in elderly patients with hip fracture. J Am Geriatr Soc 2009;57:1354-1361.
4.
Adunsky A, Levy R, Heim M, Mizrahi E, Arad M: The unfavorable nature of preoperative delirium in elderly hip fractured patients. Arch Gerontol Geriatr 2003;36:67-74.
5.
Edlund A, Lundstrom M, Brannstrom B, Bucht G, Gustafson Y: Delirium before and after operation for femoral neck fracture. J Am Geriatr Soc 2001;49:1335-1340.
6.
Inouye SK, Bogardus ST, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr: A multi component intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-676.
7.
Folstein MF, Folstein SE: Mini-mental state: a practical guide for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
8.
Freter SH, Dunbar MJ, MacLeod H, Morrison M, MacKnight C, Rockwood K: Predicting post-operative delirium in elective orthopaedic patients: the Delirium Elderly At Risk (DEAR) instrument. Age Ageing 2005;34:169-184.
9.
Freter SH, George J, Dunbar MJ, Morrison M, MacKnight C, Rockwood K: Prediction of delirium in fractured neck of femur as part of routine preoperative nursing care. Age Ageing 2005;34:387-409.
10.
Freter SH, Dunbar MJ, Koller K, MacKnight C, Rockwood K: Risk of pre- and post-operative delirium and the Delirium Elderly At Risk (DEAR) tool in hip fracture patients. Can Geriatr J 2015, in press.
11.
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI: Clarifying confusion: the Confusion Assessment Method. Ann Intern Med 1990;113:941-948.
12.
Alberta Cancer Board: Alberta Hospice Palliative Care Resource Manual, ed 2. 2001, ISBN: 1-894809-29-7.
13.
Dunn OJ: Multiple comparisons among means. J Am Statist Assoc 1961;56:52-64.
14.
Theou O, Rockwood MR, Mitnitski A, Rockwood K: Disability and co-morbidity in relation to frailty: how much do they overlap? Arch Gerontol Geriatr 2012;55:e1-e8.
15.
Eeles EMP, White SV, O'Mahony SM, Bayer AJ, Hubbard RE: The impact of frailty and delirium on mortality in older inpatients. Age Ageing 2012;41:412-416.
16.
Searle SD, Mitniski A, Gahbauer EA, Gill TM, Rockwood K: A standard procedure for creating a frailty index. BMC Geriatr 2008;8:24.
17.
Rockwood K, Andrew M, Mitnitski A: A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Med Sci 2007;62A:738-743.
18.
Leung JM, Sands LP, Lim E, Tsai TL, Kinjo S: Does preoperative risk for delirium moderate the effects of postoperative pain and opiate use on postoperative delirium? Am J Geriatr Psychiatry 2013;21:946-956.
19.
Stromberg L, Lindgren U, Nordin C, Ohlen G, Svensson O: The appearance and disappearance of cognitive impairment in elderly patients during treatment for hip fracture. Scand J Caring Sci 1997;11:167-175.
20.
Bjorkelund KB, Hommel A, Thorngren KG, Gustafson L, Larsson S, Lundberg D: Reducing delirium in elderly patients with hip fracture: a multi-factorial intervention study. Acta Anaesthesiol Scand 2010;54:678-688.
21.
Di Nino G, Adversi M, Dekel BS, Fodale V, Rosa G, Melotti RM: Peri-operative risk management in patients with Alzheimer's disease. J Alz Dis 2010;22:S121-S127.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.